TransMedics Group, Inc. (TMDX)

124,44 +6,84 (+5,82%) Alla chiusura: 04:00PM EDT

TransMedics Group, Inc.

200 Minuteman Road
Suite 302
Andover, MA 01810
United States
978 552 0900
https://www.transmedics.com

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 584

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Waleed H. Hassanein M.D.	Founder, President, CEO & Director	1,82M	13,38M	1968
Mr. Stephen Gordon	CFO, Treasurer & Secretary	909,62k	1,31M	1968
Mr. Nicholas Corcoran	Senior Vice President of Supply Chain & Operations	812,07k	N/D	1983
Mr. Anil Ranganath	Senior VP, General Counsel & Corporate Secretary	561,67k	N/D	N/D
Dr. Tamer I. Khayal M.D.	Chief Commercial Officer	900,11k	5,45M	1969
Mr. Mark Anderson	Senior Director of Technology Development	N/D	N/D	N/D
Ms. Susan Goodman	Vice President of Human Resources	N/D	N/D	N/D
Ms. Miriam C. Provost Ph.D.	Vice President of Global Regulatory Affairs	535,93k	390,25k	1961

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Governance aziendale

L'ISS Governance QualityScore di TransMedics Group, Inc. al 1 maggio 2024 è 3. I criteri di valutazione fondamentali sono revisione: 2; Consiglio di Amministrazione: 3; diritti degli azionisti: 3; retribuzione: 6.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.